Evidence map›Paper›PMID 28877991›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Activated Protein C Attenuates Severe Inflammation by Targeting VLA-3

Pranita P Sarangi, Hyun-Wook Lee, Yelena V Lerman, Alissa Trzeciak, Eric J Harrower, Alireza R Rezaie, Minsoo Kim

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pranita P SarangiDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-7877-4802
Hyun-Wook LeeDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-5428-8594
Yelena V LermanDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642; and.
Alissa TrzeciakDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-4518-0098
Eric J HarrowerDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-1051-5521
Alireza R RezaieCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0002-5302-0553
Minsoo KimDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642; minsoo_kim@urmc.rochester.edu.
University of Rochester · USOklahoma Medical Research Foundation · US

Funding

Protease Activated Receptor Signaling by Coagulation ProteasesR01HL101917 · NHLBI · SAINT LOUIS UNIVERSITY · PI Lijun Xia · 2010 to 2026
$6.6M
Neutrophil-endothelial interactions and barrier function in sepsisR01HL125265 · NHLBI · UNIVERSITY OF ROCHESTER · PI KIM, MINSOO, REICHNER, JONATHAN S · 2014 to 2018
$3.9M
Infection and Immunity: The Pathogenesis of Host-Microbe InteractionsT32AI118689 · NIAID · UNIVERSITY OF ROCHESTER · PI Paul M. Dunman, BRIAN M WARD · 2015 to 2026
$2.5M
PHARMACOLOGY OF DRUG ABUSET32DA007232 · NIDA · UNIVERSITY OF ROCHESTER · PI BIDLACK, JEAN M · 1985 to 2011
$2.1M
Identification of a Damaging Subset of Neutrophils that Arises in Septic PatientsR01HL147525 · NHLBI · RHODE ISLAND HOSPITAL · PI KIM, MINSOO, REICHNER, JONATHAN S · 2019 to 2022
$2.0M
NHLBI NIH HHS R01 HL101917NHLBI NIH HHS R01 HL125265NHLBI NIH HHS R01 HL147525NIAID NIH HHS T32 AI118689NIDA NIH HHS T32 DA007232
6 · The paper itself

Abstract

The host injury involved in multiorgan system failure during severe inflammation is mediated, in part, by massive infiltration and sequestration of hyperactive neutrophils in the visceral organ. A recombinant form of human activated protein C (rhAPC) has shown cytoprotective and anti-inflammatory functions in some clinical and animal studies, but the direct mechanism is not fully understood. Recently, we reported that, during endotoxemia and severe polymicrobial peritonitis, integrin VLA-3 (CD49c/CD29) is specifically upregulated on hyperinflammatory neutrophils and that targeting the VLA-3

Indexed as

AnimalsBiological TherapyCells, CulturedHumansInflammationIntegrin alpha3beta1LungMaleMiceMice, Inbred C57BLMultiple Organ FailureMutationNeutrophil ActivationNeutrophilsPeritonitisProtein BindingIntegrin alpha3beta1Protein CRecombinant Proteins

Identifiers

PMID28877991
PMCPMC5658029
OpenAlexW2753533377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.